News

Last winter, I donated my kidney to a stranger. As a nephrologist, I see people every day who need a gently used kidney, and ...
My illness previously dictated how I planned my days, years and entire sense of possibility – pregnancy has disrupted that ...
The 33-year-old suffered from painful migraines and then suddenly collapsed. Doctors determined he was in kidney failure and will likely need a kidney transplant.
The 33-year-old suffered from painful migraines and then suddenly collapsed. Doctors determined he was in kidney failure and will likely need a kidney transplant.
Witnessing her son's ongoing pain and deteriorating health, his mother took the brave decision to donate one of her kidneys.
Novartis AG (NYSE:NVS) is a Swiss pharmaceutical leader focused on developing innovative treatments across oncology, ...
A dual algorithm claims analysis revealed the rare burden of primary IgA nephropathy in Germany and underscored the need for precise diagnostic coding.
Game Changers in Nephrology' was the theme of the 62nd European Renal Association (ERA) Congress, held in Vienna, ...
The Company currently has a pipeline of programmes in development including the lead asset for treatment of IgA Nephropathy (IgAN) and other complement mediated kidney disease. The Company also has ...
Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 16, Leerink Partners analyst Joseph Schwartz reiterated the firm’s ...
SAN FRANCISCO and VANCOUVER, British Columbia, July 01, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: ...
The global IgA nephropathy market is anticipated to witness steady growth from 2025 to 2035, driven by the growing incidence of chronic kidney diseases and the introduction of innovative, ...